GC, MDGC
Chromatography used in vaccine development
Jul 19 2011
CHIKV is a mosquito-borne virus which is responsible for a number of large epidemics in Africa, south-east Asia and India, with invading Asian tiger mosquitoes now thought to have spread the infection to southern Europe.
After an incubation period of two to six days, patients display symptoms including joint pain, vomiting and nausea, headaches, chills and fever as well as a rash across the body.
In recent epidemics, mortality rates are thought to be as high as 33 per cent as the virus often targets the over 65s.
Using methods including metal affinity chromatography, scientists studied the CHIKV envelope proteins E1 and E2 to develop a vaccine against the virus.
"The ability of purified, secreted CHIKV-E2 to induce neutralising antibodies in rabbits underscores the potential use of E2 in a subunit vaccine to prevent CHIKV infections," the report stated.
Digital Edition
Chromatography Today - Buyers' Guide 2022
October 2023
In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Sep 04 2024 Chiba, Tokyo, Japan